Page last updated: 2024-11-05

desaspidin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Desaspidin is a natural product isolated from the fern species Dryopteris crassirhizoma. It exhibits a range of biological activities, including anti-inflammatory, anticancer, and anti-HIV properties. Its unique chemical structure, characterized by a spiroketal ring system, has made it a target of interest for synthetic chemists, with several total syntheses reported. Desaspidin's potential as a therapeutic agent has driven ongoing research to understand its mechanisms of action and explore its clinical applications. Its anti-inflammatory activity has been attributed to its ability to inhibit the production of pro-inflammatory cytokines, while its anticancer effects may involve disruption of cellular signaling pathways. Desaspidin's complex structure and its various biological activities make it a valuable subject of study for researchers investigating the development of novel pharmaceuticals.'

desaspidin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID8238
CHEMBL ID2105606
CHEBI ID135960
SCHEMBL ID2732746
MeSH IDM0045862

Synonyms (38)

Synonym
desaspidin [inn]
einecs 204-048-5
desaspidin bb
3'-((5-butyryl-2,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien-1-yl)methyl)-2',6'-dihydroxy-4'-methoxybutyrophenone
brn 2068482
desaspidinum [inn-latin]
butyrophenone, 3'-((5-butyryl-2,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien-1-yl)methyl)-2',6'-dihydroxy-4'-methoxy-
rosapin
desaspidine [inn-french]
desaspidin
desaspidina [inn-spanish]
desapidin
D07365
114-43-2
desaspidin (inn)
CHEBI:135960
2-butanoyl-4-[(3-butanoyl-2,4-dihydroxy-6-methoxyphenyl)methyl]-3,5-dihydroxy-6,6-dimethylcyclohexa-2,4-dien-1-one
60842-45-7
CHEMBL2105606
4-08-00-03747 (beilstein handbook reference)
desaspidina
desaspidinum
2,5-cyclohexadien-1-one, 2-((2,4-dihydroxy-6-methoxy-3-(1-oxobutyl)phenyl)methyl)-3,5-dihydroxy-4,4-dimethyl-6-(1-oxobutyl)-
desaspidine
kv3495sgks ,
unii-kv3495sgks
desaspidin bb [mi]
desaspidin [who-dd]
SCHEMBL2732746
GAHOBHHMYUYJDT-UHFFFAOYSA-N
3'-[(5-butyryl-2,4-dihydroxy-3,3-dimethyl-6-oxo-1,4-cyclohexadien-1-yl)methyl]-2',6'-dihydroxy-4'-methoxybutyrophenone
deaspidin
2,5-cyclohexadien-1-one, 2-[[2,4-dihydroxy-6-methoxy-3-(1-oxobutyl)phenyl]methyl]-3,5-dihydroxy-4,4-dimethyl-6-(1-oxobutyl)-
2-butyryl-6-(3-butyryl-2,4-dihydroxy-6-methoxybenzyl)-3,5-dihydroxy-4,4-dimethyl-2,5-cyclohexadien-1-one #
DTXSID6074461
DB13567
Q904668
DTXSID00976317
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1439492Antiparasitic activity against Schistosoma mansoni2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (75.00)18.7374
1990's1 (12.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]